NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Jul 2018
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 17h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
AZEDRA (iobenguane I-131) is a radiopharmaceutical therapeutic indicated for patients with iobenguane-avid, malignant pheochromocytoma or paraganglioma. It is an iodine-131 labeled norepinephrine analog that localizes to neuroendocrine tumors via uptake by the norepinephrine transporter, delivering targeted radiation therapy to tumor tissue.
Peak
AZEDRA operates in a rare disease oncology niche with limited volume; commercial teams are typically small and specialized in pheochromocytoma/paraganglioma patient identification and physician engagement.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on AZEDRA offers deep expertise in rare oncology, radiopharmaceuticals, and ultra-specialized patient populations; however, limited job openings (0 linked) and modest market size suggest a tight, expert-focused team environment. Career growth is best suited for professionals passionate about rare disease impact over high-volume commercial scale.
Medical Science Liaison
Worked on AZEDRA at Progenicyte Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.